The UK is traditionally a base for high quality pharmaceutical manufacturing, particularly of innovative medicinal products and delivery systems.
Access to skills and knowledge, a robust legal system for the protection of Intellectual Property (IP), and world class manufacturing capability have contributed to making the UK a centre for discovery and development of new medicinal products.
In the recent past, the UK has been a highly successful centre in the area of large molecules and biological innovation, and future investment in the pharmaceutical manufacturing capability in the UK to exploit this success will be encouraged.
The latest Annual Business Inquiry report published by the Office for National Statistics shows that the number of enterprises for manufacturing pharmaceuticals (basic pharmaceutical products and preparations) decreased from 461 in 2009 to 444 in 2010*.
*Source: Business Enterprise Research and Development (BERD).